KLK3, kallikrein related peptidase 3, 354

N. diseases: 358; N. variants: 19
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C3539781
Disease: Progressive cGVHD
Progressive cGVHD
0.040 Biomarker disease BEFREE Overall, 31 patients had dPSA response (46.3%), 12 stable disease (17.9%), and 24 progressive disease (35.8%). 31614001 2020
CUI: C3539781
Disease: Progressive cGVHD
Progressive cGVHD
0.040 Biomarker disease BEFREE The patients were also classified as having PD/non-PD according to the clinical and prostate-specific antigen (PSA) responses. 29447047 2018
CUI: C3539781
Disease: Progressive cGVHD
Progressive cGVHD
0.040 Biomarker disease BEFREE Comparison of AMACR RT-PCR with known serum PSA values indicated that a combination of these parameters significantly increased the sensitivity for detection of progressive disease. 17154657 2006
CUI: C3539781
Disease: Progressive cGVHD
Progressive cGVHD
0.040 Biomarker disease BEFREE Patients with greater than 25% increases in serum PSA from baseline were considered to have progressive disease and were removed from the study. 16698360 2006